Adbiotech Co (XKRX:179530) Marketable Securities : ₩630 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Adbiotech Co Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Adbiotech Co's Marketable Securities for the quarter that ended in Mar. 2024 was ₩630 Mil.

Adbiotech Co's annual Marketable Securities increased from Dec. 2021 (₩1,585 Mil) to Dec. 2022 (₩7,448 Mil) but then declined from Dec. 2022 (₩7,448 Mil) to Dec. 2023 (₩6,399 Mil).

Adbiotech Co Marketable Securities Historical Data

The historical data trend for Adbiotech Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adbiotech Co Marketable Securities Chart

Adbiotech Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

800.00

404.11

1,585.28

7,448.45

6,399.11

Adbiotech Co Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Marketable Securities	Get a 7-Day Free Trial									2,782.57	2,034.57	1,700.00	6,399.11	630.00

Adbiotech Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Adbiotech Co (XKRX:179530) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Adbiotech Co Marketable Securities Related Terms

Thank you for viewing the detailed overview of Adbiotech Co's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Adbiotech Co (XKRX:179530) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adbiotech Co Ltd (XKRX:179530) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

39, Geodudanji 1-gil, Dongnae-myeon, Gangwon-do, Chuncheon, KOR, 24398

Website

http://www.adbiotech.com

Adbiotech Co Ltd is a life science company. It develops a vaccine and antibiotic-friendly substances such as IgY, Immunoglobulin in Yolk for human, animal and fish oral antibody products, and functional cosmetics and food additives. The company aim to develop Helico IgY, Cholesterol IgY, and Ulcerative Colitis natural product medicines.

Adbiotech Co (XKRX:179530) Headlines

No Headlines